Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thursday Plantation

This article was originally published in The Tan Sheet

Executive Summary

Begins shipping seven new Tea Tree Oil products beginning Aug. 15. Tea Tree dental floss, lozenges, lip balms and cinnamon mouthwash will be supported by a $250,000 1994 ad budget. Ads will be handled by Santa Barbara, Calif.-based Mirquee Design and will include nationwide spots in regional newspapers, TV, trade and consumer publications. The company will use shelf talkers, usage fliers, posters, floor and counter displays including "eight-inch high kangaroos" for in-store promotion, in addition to a "Discover Australia" raffle promotion. Suggested retail prices are $3.99 for 50 yards of Tea Tree Dental Floss, $1.99 for Chap-Mate mint and original flavors, $2.99 for Lip-Clear, $4.99 for a six-ounce bottle of Alcohol Free Oil of Molalouca Tea Tree Cinnamon Mouthwash, and $5.99 for 30-count bottles of Tea Tree Oil Lozenges in chlorophyll or cherry flavors

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

People In Brief

Perrigo promotes in pricing, planning

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS083171

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel